Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes

Journal of Occupational and Environmental Medicine

Volumn 47, Issue 5, 2005, Pages 447-452

  Rhoads, George G ^a   Orsini, Lucinda S ^b   Crown, William ^b   Wang, Shoahung ^b   Getahun, Darios ^a   Zhang, Quanwu ^c  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b MEDSTAT GROUP   (United States)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ABSENTEEISM; ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE;

EID: 18544362046     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000161727.03431.3e     Document Type: Article

References (22)

1. Goetzel RZ, Ozminkowski RJ, Meneades L, Stewart M, Schutt DC. Pharmaceuticals - cost or investment? J Occup Environ Med. 2000;42:338-351.
2. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med. 2003;45:5-14.
3. Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med. 2004;46:398-412.
4. Diabetes Control and Complications Research Group. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care. 1995;18:361-376.
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
6. Johnson ES, Koepsell TD, Reiber G, Stergachis A, Platt R. Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol. 2002;55:253-259.
7. Nilsson A, Tideholm B, Kalen J, Katzman P. Incidence of severe hypoglycemia and its causes in insulin-treated diabetics. Acta Med Scand. 1988;224:257-62.
8. Gold AE, MacLeod AM, Frier BM. Frequency of severe hypoglycemia in patients with type 1 (insulin dependent) diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17:697-703.
9. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabetes Med. 2003;20:1016-21.
10. Muhlhauser I, Berger M, Sonnenberg G, et al. Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus. Diabetes Care. 1985;8:268-273.
11. Holstein A, Plaschke A, Egberts E-H. Incidence and costs of severe hypoglycemia (letter). Diabetes Care 2002;25:2109.
12. Pieber TR, Eugène-Jolchine I, Derobert E, and the European Study Group of HOE 901 in Type I Diabetes. Diabetes Care. 2000;23:157-62.
13. Ratner RE, Hirsch IB, Neifing, JL, et al. Less hypoglycemia with insulin glargine in intensive insulin therapy for Type I diabetes. Diabetes Care. 2000;23:639-643.
14. Orsini L, Limpa-Amara S, Crown W, Stanford RH. Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs. montelukast. Ann Allergy Asthma Immunol. 2004;92:523-529.
15. Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000;284:1655-1663.
16. Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatr. 2002;63:963-971.
17. Javitz H., Ward MM., Farber E, Nail L, Vallow SG. The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol. 2002;46:850-860.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383.
19. Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabetes Med. 1993;10:231-237.
20. Rosenstock J, Schwartz SL, Clark CM Jr., Park GD, Donley DW, Edwards MB. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care. 2001;24:631-636.
21. Barnett AH. A review of basal insulins. Diabetes Med. 2003;20:873-885.
22. Rosenstock J. Basal insulin supplementation in type 2 diabetes; refining the tactics. Am J Med. 2004;116(Suppl 3A): 10S-16S.